Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a …
Over the last 12 months, insiders at Revelation Biosciences, Inc. have bought $0 and sold $0 worth of Revelation Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Revelation Biosciences, Inc. have bought $151,908 and sold $2.26M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $29,000 was made by TIDMARSH GEORGE F (director) on 2023‑04‑18.
2023-12-08 | Sale | director | 27,771 0.4059% | $0.52 | $14,438 | -88.48% | ||
2023-10-16 | Sale | director | 12,802 0.1963% | $0.66 | $8,442 | -88.31% | ||
2023-09-28 | Sale | director | 1,429 0.0232% | $0.69 | $986 | -88.01% | ||
2023-09-18 | Sale | director | 4,000 0.0648% | $0.74 | $2,960 | -88.05% | ||
2023-09-15 | Sale | director | 9,500 0.1449% | $0.73 | $6,935 | -88.60% | ||
2023-09-14 | Sale | director | 12,000 0.1906% | $0.75 | $9,000 | -88.44% | ||
2023-04-18 | director | 25,000 1.1925% | $1.16 | $29,000 | -38.61% | |||
2023-04-17 | director | 26,500 1.1885% | $1.16 | $30,740 | -42.24% | |||
2022-02-25 | 20,000 0.1609% | $1.60 | $32,000 | -70.02% | ||||
2022-02-09 | 30,000 0.2157% | $2.55 | $76,599 | -81.48% | ||||
2022-02-08 | 1,000 0.007% | $2.54 | $2,540 | -81.68% | ||||
2022-02-07 | 42,100 0.2939% | $2.61 | $109,780 | -82.13% | ||||
2022-02-04 | 9,900 0.0679% | $2.34 | $23,156 | -80.31% | ||||
2021-09-23 | Sale | 10 percent owner | 611,541 4.7291% | $10.08 | $6.16M | -87.29% | ||
2021-09-22 | Sale | 10 percent owner | 5 <0.0001% | $10.08 | $50 | -87.29% | ||
2021-09-21 | Sale | 10 percent owner | 43,000 0.3323% | $10.08 | $433,440 | -87.20% | ||
2020-11-09 | Sale | 10 percent owner | 5,000 0.0396% | $10.00 | $50,000 | +1388373.68% | ||
2020-10-12 | Sale | 10 percent owner | 20 0.0002% | $10.00 | $200 | +1386811.84% | ||
2020-10-09 | Sale | 10 percent owner | 9,328 0.0738% | $10.00 | $93,280 | +1386314.47% |
TIDMARSH GEORGE F | director | 0 0% | $0.35 | 7 | 6 | <0.0001% |